KH
Kensuke Hata
About Kensuke Hata
Data last updated:
Kensuke Hata was an Additional Director at Medreich Limited (2022), Additional Director at Adcock Ingram Limited (2022) and Additional Director at Adcock Ingram Pharma Private Limited (2022). The companies operate in Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 01 Apr 2022 | 1973 | ₹1,737 Cr (FY 2024) | Active | |
| Additional Director | 21 Jun 2022 | 2007 | ₹464 Cr (FY 2025) | Active | |
| Additional Director | 21 Jun 2022 | 2021 | ₹47.27 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kensuke Hata
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kensuke Hata
Kensuke Hata was first appointed on 01 Apr 2022 as Additional Director at Medreich Limited.
Kensuke Hata held 3 earlier board appointments: Medreich Limited (Additional Director, 01 Apr 2022 to 29 Sep 2022); Adcock Ingram Limited (Additional Director, 21 Jun 2022 to 28 Sep 2022); Adcock Ingram Pharma Private Limited (Additional Director, 21 Jun 2022 to 28 Sep 2022).